Meet with our product experts in one-on-one virtual sessions and get a deep insight into our API Pharma Products offerings.

Our experts will answer your questions, provide advice, and help you understand our product better.

Set up a meeting

Verified

About Us:

Dr. Reddy’s Laboratories Ltd. is an integrated pharmaceutical company committed to providing affordable and innovative medicines for healthier lives. Through its three businesses - Pharmaceutical Services & Active Ingredients, Global Generics, and Proprietary Products – Dr. Reddy’s is an active pharmaceutical ingredient supplier for foremost formulators and offers a portfolio of products and services, including APIs, custom pharmaceutical services, generics, biosimilars, and differentiated formulations.

As an active pharmaceutical ingredient manufacturer, our major therapeutic areas of focus are gastrointestinal, cardiovascular, diabetology, oncology, pain management, and dermatology. Dr. Reddy’s operates in markets across the globe. Our major markets include – USA, Europe, India, Russia, and other CIS countries.

Dr. Reddy's recognized at the CPhI Pharma Awards 2020 as the winner in the category of 'Excellence in Pharma: Sustainability'

At CPHI 2020 - We are honoured that our sustainability initiative has been recognized with the CPhI Pharma Award 2020 in the category of ‘Excellence..

At CPHI 2021 - Dr. Reddy's have been shortlisted for Excellence in Pharma

At CPHI 2021 - Dr. Reddys have been shortlisted for Excellence in Pharma: Regulatory Procedures and Compliance

The Portfolio of Dr. Reddy’s API Offerings

The Portfolio of Dr. Reddy’s API Offerings

Our Team

Renuncia

Ninguna información en este catálogo, incluida cualquier referencia a cualquier producto o servicio, constituye una oferta de venta, ni debe interpretarse como representación de una oferta de venta. Los productos protegidos por patentes válidas no se ofrecen ni se suministran para uso comercial. Sin embargo, las cantidades de investigación de dichos productos pueden ofrecerse con el fin de presentaciones reglamentarias, siempre que existan dichas exenciones reglamentarias. Los compradores deben realizar una evaluación independiente del escenario de la patente para sus respectivos mercados y serán responsables de todas las responsabilidades relacionadas con la patente. Los productos protegidos por patentes válidas en la India no están disponibles para uso comercial, pero estarían disponibles para los fines de la Sección 107A.